Mostrando títulos en Biotecnología

Este audiolivro contribui para a compreensão do Déficit de Atenção e Hiperatividade, por meio de uma rica abordagem em que a mente e a inteligência ocupam papel de destaque.

La materia è intelligente. Solitamente pensiamo i materiali che ci circondano come semplici strumenti, passivi e incapaci di interagire con l’ambiente in modo complesso, ma a ben guardare non è affatto così. Numerosi materiali sono in grado di adattarsi agli stimoli che ricevono, di assemblarsi e ripararsi in autonomia e, in alcuni casi, di conservare una memoria del proprio passato.

The microbiome is the missing link in modern medicine: a vast genetic universe of bacteria, yeasts, viruses and parasites that live inside us, influencing every aspect of our health, even the way we think and feel. In this mindblowing book, scientist and surgeon James Kinross explains how the organisms that live within us have helped us evolve, shaped our biology and defined the success of our species. With dazzling science and fascinating stories, this pioneering book will change the way you think about human health forever.

Jim Geraghty has been a passionate participant in the orphan drug revolution since its inception―a leader in the field as a strategy consultant, biotechnology executive, and venture entrepreneur. His book is in part a history, with eyewitness accounts of advances as they occurred and portraits of the pioneering scientists and physicians, tireless activists, and visionary business leaders who made the revolution happen. And it tells deeply personal stories of patients and parents willing to risk untried new therapies.

Science journalist Sally Adee breaks open the field of bioelectricity—the electric currents that run through our bodies and every living thing—its misunderstood history, and why new discoveries will lead to new ways around antibiotic resistance, cleared arteries, and new ways to combat cancer.

This publication entitled (Stem Cells The Future of Health Restoration) is an audiobook, including preliminary sections describing stem cells' importance to human health. The author of this book attempts to do justice to the subject matter by discussing it in six different chapters and a concluding chapter. Each chapter explains different subthemes relating to the book's central theme.

Scientific discoveries in the field of genomics just began about 50 years ago. These breakthroughs answered many questions about how we are built and live. The discoveries also proved the power and importance of the tiny chromosome.

In Nature's Wild Ideas, Kristy Hamilton goes behind the scenes of some of our most unexpected innovations. She traverses frozen waterfalls, treks through cloudy forests, discovers nests in the Mojave desert, scours intertidal zones, and takes us to the deepest oceans and near volcanoes to introduce us to the animals and plants that have inspired everything from cargo routing systems to non-toxic glues, and the men and women who followed that first spark of "I wonder" all the way to its conclusion, sometimes against all odds.

Millions of data enthusiasts from around the world compete on Kaggle, the most famous data science competition platform of them all. Participating in Kaggle competitions is a surefire way to improve your data analysis skills, network with an amazing community of data scientists, and gain valuable experience to help grow your career. The first audiobook of its kind, The Kaggle Book assembles in one place the techniques and skills you'll need for success in competitions, data science projects, and beyond.

Beginning in the 1970s, several scientific breakthroughs promised to transform the creation of new medicines. As investors sought to capitalize on these Nobel Prize-winning discoveries, the biotech industry grew to thousands of small companies around the world. Each sought to emulate what the major pharmaceutical companies had been doing for a century or more, but without the advantages of scale, scope, experience, and massive resources. From Breakthrough to Blockbuster focuses on both the companies themselves and the broader biotech ecosystem that supports them.

A riveting, fast-paced inside look at one of the most incredible private-sector achievements in history, Moonshot recounts the intensive nine months in 2020 when the scientists at Pfizer, under the visionary leadership of Dr Albert Bourla, made 'the impossible possible' - creating, testing and manufacturing a safe and effective COIVD-19 vaccine that previously would have taken years to develop.

A lo largo del último siglo, la humanidad ha logrado lo imposible frenando la hambruna, la peste y la guerra. Por primera vez en la historia, más personas mueren por obesidad que por pasar hambre y hay más probabilidades de quitarse la vida que de morir en un conflicto bélico o un atentado terrorista.

Vaincre le handicap, la maladie et le vieillissement : une enquête inédite sur le l'homme du futur. Remplacer un bras, une jambe par un membre mécatronique ; concevoir des yeux bioniques pour résoudre les problèmes de cécité ; cultiver dans des cochons des organes destinés à être greffés sur l'homme ; donner la vie grâce à un utérus artificiel ; créer ou effacer des souvenirs ; connecter un cerveau à une intelligence artificielle ; freiner le vieillissement en manipulant l'ADN ; congeler un corps pour le réveiller un siècle plus tard...

Heroic science. Chaotic politics. Billionaire entrepreneurs. Award-winning journalist Brendan Borrell brings the defining story of our times alive through thoroughly enjoyable first-time reporting on the players leading the fight against a vicious virus. The First Shots draws on exclusive high-level access to weave together the intense vaccine-race conflicts among hard-driving, heroic scientists and the epic rivalries among Washington power players that shaped 18 months of fear, resolve, and triumph.

Animals make for terrible technology. The technological use of animals - making food, drugs, clothing, and cosmetics out of animal material - will cease. After Meat explains the fundamental limits of animal technology in terms of physics and biology. Replacement technology such as microbial fermentation will surpass those limits. Eventually, we’ll have food that is better in every way - in terms of taste, cost, nutrition, resource consumption, and ethics - because we won't use animals to produce it.

Join journalist Barry Werth as he pulls back the curtain on Vertex, a start-up pharmaceutical company, and witness firsthand the intense drama being played out in the pioneering and hugely profitable field of drug research. Founded by Joshua Boger, a dynamic Harvard- and Merck-trained scientific whiz kid, Vertex is dedicated to designing - atom by atom - both a new life-saving immunosuppressant drug and a drug to combat the virus that causes AIDS.

Once, we humans could only observe evolution. Suddenly, we had conquered it. And yet, in Life as We Made It, evolutionary biologist Beth Shapiro argues that - despite how amazing our new technologies are - our ability to alter the course of evolution isn’t new. What is new is that where once we shaped evolution through brute force, we can now do it as artisans. That power comes not a moment too soon. If we are going to survive in the next few centuries, we must revise the book of life.

Few were ready when a mysterious respiratory illness emerged in Wuhan, China, in January 2020. Politicians, government officials, business leaders, and public-health professionals were unprepared for the most devastating pandemic in a century. Many of the world’s biggest drug and vaccine makers were slow to react or couldn’t muster an effective response. It was up to a small group of unlikely and untested scientists and executives to save civilization.

In the fall of 1980, Genentech, Inc., a little-known California genetic engineering company, became the overnight darling of Wall Street, raising over $38 million in its initial public stock offering. Lacking marketed products or substantial profit, the firm nonetheless saw its share price escalate from $35 to $89 in the first few minutes of trading. Coming at a time of economic recession and declining technological competitiveness in the United States, the event ignited a period of speculative frenzy over biotechnology.

In this lecture, Professor Kahn will examine the state of health care and biomedical research in the US and around the globe, through the lens of ethics. The lecture will start with some historical context and examples from bioethics, and draw some parallels from the past for the current state of our public discussions on a range of controversial bioethics issues.